MedTrace Logo

Quest for Tumour Evolution of Non-small Cell Lung Cancer

NCT05811169 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-04-13

No results posted yet for this study

Summary

To study and comprehend the evolutionary and genomic landscape between primary and metastatic sites and the dynamics of intratumour and intertumour heterogeneity over time with reference to the treatment modalities for each Chinese patient with non-small cell lung cancer.

Conditions

Interventions

GENETIC

Next generation sequencing

Next generation sequencing

Sponsors & Collaborators

  • Queen Mary Hospital, Hong Kong

    collaborator OTHER

  • Queen Elizabeth Hospital, Hong Kong

    collaborator OTHER

  • Pamela Youde Nethersole Eastern Hospital

    collaborator OTHER

  • Prince of Wales Hospital, Shatin, Hong Kong

    collaborator OTHER

  • Princess Margaret Hospital, Hong Kong

    collaborator OTHER_GOV

  • Tuen Mun Hospital

    collaborator OTHER_GOV

  • United Christian Hospital

    collaborator OTHER

  • The University of Hong Kong

    lead OTHER

Principal Investigators

  • Victor Ho-Fun Lee, MD · The University of Hong Kong

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2025-12-31
Completion
2026-12-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05811169 on ClinicalTrials.gov